A SOLUBILITY-ENHANCED PHARMACEUTICAL FORMULATION COMPRISING SILODOSIN
The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention relates to a pharmaceutical formulation and a producing method thereof, comprising a solid dispersion formed by making silicon dioxide adsorb silodosin or a pharmaceutically acceptable salt thereof. The silodosin or the pharmaceutically acceptable salt thereof and povidone are mixed at the ratio of 1 : 0.5 to 2 parts by weight, and elution properties of silodosin can be improved.
본 발명은 실로도신 또는 이의 약학적으로 허용가능한 염이 이산화규소에 흡착되어 형성된 고체 분산체를 포함하는 약제학적 제제 및 이의 제조방법에 관한 것으로, 실로도신의 용출 특성이 향상되는 효과가 있다. |
|---|